In vivo phage display identifies novel peptides for cardiac targeting

Area of Science:

• Cardiovascular Research
• Biotechnology
• Regenerative Medicine

Background:

• Heart failure is a major cause of death globally.
• Targeted delivery of therapeutics to damaged heart tissue is crucial for effective treatment.

Purpose of the Study:

• To identify novel peptides that specifically target damaged cardiac tissue.
• To develop a bioinformatics pipeline for identifying cardiac-targeting peptides.

Main Methods:

• In vivo peptide phage display was employed to screen for cardiac-targeting peptides.
• High-throughput Next-Generation Sequencing (NGS) was utilized for peptide identification.
• A bioinformatics pipeline was established for efficient analysis.

Main Results:

• Several novel peptides were identified that specifically target damaged cardiac tissue.
• Hit peptides demonstrated preferential uptake in human induced pluripotent stem cell (iPSC)-derived cardiomyocytes and mouse HL1 cardiomyocytes.
• Minimal uptake was observed in human liver HepG2 cells, indicating specificity.

Conclusions:

• The identified peptides are promising candidates for targeted drug delivery in heart failure.
• These peptides offer potential for regenerative strategies in cardiovascular medicine.
• This research opens new avenues for cardiovascular research and clinical applications.